Brokerages expect that Tabula Rasa HealthCare Inc (NASDAQ:TRHC) will post earnings per share (EPS) of $0.26 for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Tabula Rasa HealthCare’s earnings. The lowest EPS estimate is $0.20 and the highest is $0.32. Tabula Rasa HealthCare reported earnings per share of $0.09 in the same quarter last year, which indicates a positive year-over-year growth rate of 188.9%. The company is expected to issue its next earnings report on Monday, March 11th.
On average, analysts expect that Tabula Rasa HealthCare will report full-year earnings of $0.82 per share for the current fiscal year, with EPS estimates ranging from $0.68 to $0.96. For the next fiscal year, analysts forecast that the firm will report earnings of $1.13 per share, with EPS estimates ranging from $0.90 to $1.50. Zacks Investment Research’s EPS averages are an average based on a survey of analysts that cover Tabula Rasa HealthCare.
Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its quarterly earnings data on Tuesday, November 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.19 by $0.07. Tabula Rasa HealthCare had a negative net margin of 16.78% and a positive return on equity of 4.55%. The company had revenue of $54.42 million during the quarter, compared to analysts’ expectations of $52.87 million. During the same quarter in the prior year, the company earned $0.08 EPS. The firm’s revenue was up 66.3% on a year-over-year basis.
In other Tabula Rasa HealthCare news, CEO Calvin H. Knowlton sold 8,000 shares of the stock in a transaction on Friday, September 7th. The shares were sold at an average price of $85.98, for a total transaction of $687,840.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold a total of 40,000 shares of company stock valued at $3,145,920 in the last three months. 14.00% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Rhumbline Advisers boosted its position in Tabula Rasa HealthCare by 9.4% during the 3rd quarter. Rhumbline Advisers now owns 39,505 shares of the company’s stock valued at $3,207,000 after buying an additional 3,386 shares during the period. Prudential Financial Inc. boosted its position in Tabula Rasa HealthCare by 21.8% during the 3rd quarter. Prudential Financial Inc. now owns 28,500 shares of the company’s stock valued at $2,314,000 after buying an additional 5,100 shares during the period. Dimension Capital Management LLC purchased a new stake in Tabula Rasa HealthCare during the 3rd quarter valued at $461,000. IFG Advisory LLC purchased a new stake in Tabula Rasa HealthCare during the 3rd quarter valued at $378,000. Finally, Virginia Retirement Systems ET AL purchased a new stake in Tabula Rasa HealthCare during the 3rd quarter valued at $365,000. 75.88% of the stock is owned by institutional investors and hedge funds.
Shares of Tabula Rasa HealthCare stock traded up $7.66 during trading on Wednesday, reaching $74.93. The company’s stock had a trading volume of 590,700 shares, compared to its average volume of 347,851. Tabula Rasa HealthCare has a 52-week low of $27.00 and a 52-week high of $91.16. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of -1,873.25, a price-to-earnings-growth ratio of 5.88 and a beta of 2.58. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.33 and a current ratio of 0.36.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.